Tower Research Capital LLC (Trc) Profound Medical Corp. Transaction History

Tower Research Capital LLC (Trc)

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$7.3 - $9.46 $2,277 - $2,951	-312 Reduced 75.18%	103 $0
Q4 2023 Feb 13, 2024	BUY	$7.85 - $11.18 $3,257 - $4,639	415 New	415 $3,000
Q2 2023 Aug 14, 2023	BUY	$9.27 - $14.88 $24,917 - $39,997	2,688 Added 850.63%	3,004 $39,000
Q1 2023 May 09, 2023	BUY	$8.85 - $13.27 $2,796 - $4,193	316 New	316 $3,000
Q3 2022 Nov 10, 2022	BUY	$3.99 - $9.3 $4,177 - $9,737	1,047 Added 51.0%	3,100 $13,000
Q2 2022 Aug 15, 2022	BUY	$6.34 - $9.53 $12,153 - $18,269	1,917 Added 1409.56%	2,053 $15,000
Q1 2022 May 12, 2022	SELL	$8.16 - $11.33 $1,036 - $1,438	-127 Reduced 48.29%	136 $1,000
Q4 2021 Feb 14, 2022	BUY	$10.38 - $15.2 $2,729 - $3,997	263 New	263 $3,000
Q3 2021 Nov 15, 2021	SELL	$13.6 - $17.88 $7,208 - $9,476	-530 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$16.0 - $20.59 $7,568 - $9,739	473 Added 829.82%	530 $9,000
Q1 2021 May 17, 2021	BUY	$19.16 - $28.09 $1,092 - $1,601	57 New	57 $1,000

8.93M

1.2K

Ticker PROF
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,851,300
Market Cap $146M
Description
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.